Literature DB >> 17115899

Blocking monoclonal antibodies specific for mouse IFN-alpha/beta receptor subunit 1 (IFNAR-1) from mice immunized by in vivo hydrodynamic transfection.

Kathleen C F Sheehan1, Koon Siew Lai, Gavin P Dunn, Allen T Bruce, Mark S Diamond, Jennifer D Heutel, Corazon Dungo-Arthur, Javier A Carrero, J Michael White, Paul J Hertzog, Robert D Schreiber.   

Abstract

Herein we report the generation of mouse monoclonal antibodies (mAbs) specific for the IFNAR-1 subunit of the mouse interferon-alpha/beta (IFN-alpha/beta) receptor (MAR1 mAbs) that block type I IFN receptor signaling and biologic response induction in vitro and in vivo. These mAbs were generated from Ifnar1 (/) mice immunized by in vivo hydrodynamic transfection with a plasmid encoding the extracellular domain (ECD) of murine IFNAR-1. All MAR1 mAbs bound native receptor expressed on cell surfaces and immunoprecipitated IFNAR-1 from solubilized cells, and two mAbs also detected IFNAR-1 by Western blot analysis. in vitro, the mAbs prevented ligand-induced intracellular signaling and induction of a variety of type I IFN-induced biologic responses but had no effect on IFN-gamma-induced responses. The most effective in vitro blocker, MAR1-5A3, also blocked type I IFN-induced antiviral, antimicrobial, and antitumor responses in vivo. We also explored whether murine IFNAR-1 surface expression required the presence of Tyk2. In contrast to Tyk2-deficient human cell lines, comparable IFNAR-1 expression was found on primary cells derived either from wild-type or Tyk2 (/) mice. These mAbs represent much needed tools to more clearly elucidate the biochemistry, cell biology, and physiologic function of the type I IFNs and their receptor in mediating host-protective immunity and immunopathology.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17115899     DOI: 10.1089/jir.2006.26.804

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  161 in total

1.  Contribution of a TANK-binding kinase 1-interferon (IFN) regulatory factor 7 pathway to IFN-γ-induced gene expression.

Authors:  Matthias Farlik; Birgit Rapp; Isabelle Marie; David E Levy; Amanda M Jamieson; Thomas Decker
Journal:  Mol Cell Biol       Date:  2012-01-17       Impact factor: 4.272

Review 2.  Cytokine-receptor interactions as drug targets.

Authors:  Gideon Schreiber; Mark R Walter
Journal:  Curr Opin Chem Biol       Date:  2010-07-07       Impact factor: 8.822

3.  Spontaneous autoimmunity in the absence of IL-2 is driven by uncontrolled dendritic cells.

Authors:  Sara H Isakson; Shoshana D Katzman; Katrina K Hoyer
Journal:  J Immunol       Date:  2012-07-09       Impact factor: 5.422

4.  Mapping and Role of the CD8+ T Cell Response During Primary Zika Virus Infection in Mice.

Authors:  Annie Elong Ngono; Edward A Vizcarra; William W Tang; Nicholas Sheets; Yunichel Joo; Kenneth Kim; Matthew J Gorman; Michael S Diamond; Sujan Shresta
Journal:  Cell Host Microbe       Date:  2017-01-11       Impact factor: 21.023

Review 5.  Maternal-Fetal Transmission of Zika Virus: Routes and Signals for Infection.

Authors:  Bin Cao; Michael S Diamond; Indira U Mysorekar
Journal:  J Interferon Cytokine Res       Date:  2017-04-12       Impact factor: 2.607

6.  Critical role for interferon regulatory factor 3 (IRF-3) and IRF-7 in type I interferon-mediated control of murine norovirus replication.

Authors:  Larissa B Thackray; Erning Duan; Helen M Lazear; Amal Kambal; Robert D Schreiber; Michael S Diamond; Herbert W Virgin
Journal:  J Virol       Date:  2012-10-03       Impact factor: 5.103

7.  Blocking IFNAR1 inhibits multiple myeloma-driven Treg expansion and immunosuppression.

Authors:  Yawara Kawano; Oksana Zavidij; Jihye Park; Michele Moschetta; Katsutoshi Kokubun; Tarek H Mouhieddine; Salomon Manier; Yuji Mishima; Naoka Murakami; Mark Bustoros; Romanos Sklavenitis Pistofidis; Mairead Reidy; Yu J Shen; Mahshid Rahmat; Pavlo Lukyanchykov; Esilida Sula Karreci; Shokichi Tsukamoto; Jiantao Shi; Satoshi Takagi; Daisy Huynh; Antonio Sacco; Yu-Tzu Tai; Marta Chesi; P Leif Bergsagel; Aldo M Roccaro; Jamil Azzi; Irene M Ghobrial
Journal:  J Clin Invest       Date:  2018-05-14       Impact factor: 14.808

Review 8.  Recent Advances in Animal Models of Zika Virus Infection.

Authors:  Shupeng Dong; Qiming Liang
Journal:  Virol Sin       Date:  2018-03-14       Impact factor: 4.327

9.  Persistent LCMV infection is controlled by blockade of type I interferon signaling.

Authors:  John R Teijaro; Cherie Ng; Andrew M Lee; Brian M Sullivan; Kathleen C F Sheehan; Megan Welch; Robert D Schreiber; Juan Carlos de la Torre; Michael B A Oldstone
Journal:  Science       Date:  2013-04-12       Impact factor: 47.728

10.  Interferon regulatory factor IRF-7 induces the antiviral alpha interferon response and protects against lethal West Nile virus infection.

Authors:  Stephane Daffis; Melanie A Samuel; Mehul S Suthar; Brian C Keller; Michael Gale; Michael S Diamond
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.